More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.38B
EPS
-0.26
P/E ratio
--
Price to sales
2.93
Dividend yield
--
Beta
1.862126
Previous close
$10.88
Today's open
$10.83
Day's range
$10.76 - $11.05
52 week range
$5.37 - $14.26
show more
CEO
Mike Nassif
Employees
2636
Headquarters
Lansing, MI
Exchange
Nasdaq Global Select
Shares outstanding
218306034
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
PRNewsWire • Nov 12, 2026

Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?
Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Nov 5, 2026

Neogen® To Participate in 2026 UBS Global Healthcare Conference
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2026 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 10. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock,.
Business Wire • Nov 3, 2026

NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.
Zacks Investment Research • Oct 20, 2026

Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa. , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
GlobeNewsWire • Oct 15, 2026

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company's possible violations of the federal securities laws.
GlobeNewsWire • Oct 15, 2026

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws.
GlobeNewsWire • Oct 14, 2026

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
Zacks Investment Research • Oct 9, 2026

Neogen Corporation: Promising Recurring Demand With Food Safety
I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.
Seeking Alpha • Oct 8, 2026

Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.
MarketBeat • Oct 8, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Neogen Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.